Member Info for Tyke68

Cautious

I keep trying to be optimistic but my self imposed deadline is good news within next 3 months.

Regarding the trial it appears to be a very competitive business. Not many GBM participants around (thankfully) so maybe not as prestigious as doing trials for other cancers. We really need CC to get the results published. Could GaM be the magical cancer elixir then maybe the possible partner comes back to us and what would be even better is somebody else funds the trial and not us shareholders via “shenanigans”

Let Mike concentrate on the imaging side which is his forte and let somebody else sort out the trials.

Many thanks

Sorry I forgot to mention the EAP is still ongoing, will that show how good GaM is and influence a possible buyer/partner?

Thanks

Afternoon

The reasons phase 2 isn’t happening I was told were:

Phase 1 results have not been released yet, 1 person is still being treated which is great news, unsure when CC/JC will publish for peer review

Our prospective partner hospital kept delaying in signing (influenced by results not being confirmed?)

All this was distracting from the imaging work

So the decision to not start the phase 2 trial which would take approx 1 year to prepare and a further 3 years to complete was taken.

If we look at from the perspective of get some sales for imaging, build some momentum as MS can concentrate on just that side. If we self funded would we have to dilute further to raise the capital (2.5m) so that raises the prospect of “shenanigans” again. We still own the data and all the designations so surely that is worth an amount surely? Let’s see what happens when the results are finally released is it the magical cancer elixir?

Hopefully this month we will get a comprehensive update and possibly phase 1 results. Maybe an update on signed new contracts. How is the revenue of our new partnership going? We don’t know for definite.

What we do know is Mike has to start showing this world leading tech can generate increased revenues.

If he can’t then will TB jettison IB?

I reckon we should know far more within the next 3 months, update, phase 1 and annual results. The board can’t hide from them and need to demonstrate a cohesive plan going forward.

Just my thoughts based on discussion with Mr Brown.

Thanks

Need to remember 4p only equates to £10m mcap

A few confirmed sales and we could be above that easily.

Sales, publicity etc create a buzz. This is mike’s full time job now and not distracted by GaM. No excuses we want results and confirmed sales

Thanks

Xviolet

If the phase 1 results are expected then I suspect we will get a decent rise even though we aren’t currently doing a phase 2 trial.

The question would be if TB/MS/KS thinks it better to sell the data (and all the designations) to another company who can afford the phase 2 via MCW? and maybe we could receive further compensation if it does get FDA approval.

Plus we need MS to start informing us of any signed contracts and their possible valuations/revenues.

We have the world leading tech and possible magical elixir for cancer treatment but we are only valued at £1.3m. We need to create a buzz about our products and start to get noticed.

Get on national news not just Wisconsin

Then the world news

Thanks

Linandy

Totally agree but we have to start somewhere

Thanks

It must be pay day and a few people willing to take the risk. Good luck to them.

What we need is Mike to start telling us of any signed new contracts. Build a bit of momentum.

Thanks

What goes up must come down

With all the tweets, LinkedIn posts etc are we starting to see MS and teams focus being on the imaging side?

I still think we should be targeting NHS trusts and others around the world. Saves money, time, will cut waiting lists, mentions the buzz word AI etc.

Have a good weekend everybody

Thanks

Thanks Kane

I would like to know if they are speaking to the likes of nhs trusts. Put an advert in the bmj, get international growth etc

Likewise when we get the phase 1 results have it posted all around the world. See if any drug company notices and is interested in buying or licensing it.

Thanks

Kane

Has there been another tweet apart from the one max shared yesterday?

Thanks

Max

The person who commented on the post from yesterday, I wish he could help us. His info says took a $2m pa business to a $1bn sale.

Even Kane would be happy with that.

We can but hope

Thanks

Let’s hope that transfers into revenue

Too late for last year’s result but it would be good if they give an update if an upturn in sales this year

Thanks

This is probably a good place to keep checking for the results to see if they have been published.

https://www.researchgate.net/profile/Christopher-Chitambar

Thanks

Max

Hopefully the phase 1 results and RWD would assist if they went this way. But I think more likely to sell the rights to somebody with bigger pockets.

Thanks

Kane

I would agree it should be a red flag but in this instance I would say it is not due to what AM said. I will not elaborate on it but it is not market sensitive information.

Kane I seriously think we as shareholders have 3 options

1, think it is all a bunch of lies in which case I also would cash in

2, not want to risk any more and cut your losses and again cash in

3, currently, believe in the BoD, stay invested and see what happens over the next 3 months.

Whatever we discuss on here isn’t going to change what happens. We can argue, comment negatively etc about the BoD but if people feel that strongly then why stay?

Investors have to make their own decisions based on their own thoughts and circumstances. I am firmly in option 3, whether I stay like that will depends on what happens in the future.

The sp seems to have stabilised at this level and I can’t see it varying until we get another RNS.

Things that influence my option

•hopefully an indication of greater revenue

•possibly the sale of part of IB tech

•the phase 1 results, which are out of IB’s control.

•GaM could still be a possibility saleable asset as Max has pointed out

True and KS are suffering with their investments as well. We all hope there is a plan and as TB said we will hopefully get a comprehensive update in February. Until we have more information I can see no point in much more discussions. I hate to say it but I think it was semantic who quoted WB I believe and talked about not checking on the too often.

Thanks

AM is not a director of IBAI, hence not involved in the boards decision.

Thanks

He honestly didn’t know and asked about the EAP. Wasn’t it the EAP he contributed to so at a guess could be more important to him in the short term.

Let’s see what the results bring. I guess we are waiting for CC and JC to publish and then gauge the reaction especially if the RWD from the EAP is positive as well.

The magical elixir for cancer needs to be trialled far more

Thanks

AM didn’t know the phase 2 trial wasn’t going ahead until I told him.

Thanks

I would hope it is worth far more £1m

Thanks

Cheers Max

Hopefully Shrek (and Trek plus a few others) will be back someday. The imaging side is worth far more than £1m. It just needs promoting and now Mike has more time to concentrate on that maybe we will get that “organic growth” and subsequent sp increase.

5p is still only £12.5m mcap. Google probably spends that on its free employee cafeteria’s

Thanks